Medication info

Encaine Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White cream
Packaging
For domestic use - 10 grams/tube, For domestic use - 100 grams/tube, For domestic use - 500 grams/bottle, For export - 10 grams/tube, For export - 100 grams/tube, For export - 500 grams/bottle, For export - 30 grams/tube
Approval status
Active

MFDS item code 200600806 · Notified 2006.01.18

Summary

Main use
Pain relief through surface anesthesia during treatment of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., curettage of molluscum contagiosum), apply 1.5-2g/10cm2 of this medicine for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 of this medicine for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomas, apply approximately 5~10g of this medicine to the treatment area for 5-10 minutes, then remove it and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, not exceeding 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.
Children's dosage
○ Infants 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm2.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Pain relief through surface anesthesia during treatment of the skin, genital mucosa, and leg ulcers

View approved original text

This medicine is used to anesthetize the skin surface when inserting a syringe needle or during superficial surgical procedures. It can also be applied when surface anesthesia of the mucous membrane of the genital area is required, for example, before the removal of condyloma. Additionally, it is used for anesthetizing the skin surface before performing cleaning or superficial surgeries in areas such as leg ulcers, before removing fibrin, pus, or necrotic areas. It safely and effectively provides local anesthesia in various situations, reducing discomfort for patients.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., curettage of molluscum contagiosum), apply 1.5-2g/10cm2 of this medicine for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 of this medicine for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomas, apply approximately 5~10g of this medicine to the treatment area for 5-10 minutes, then remove it and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, not exceeding 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.

Children's dosage

○ Infants 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm2.

Precautions

This drug is used as a local anesthetic but carries the risk of methemoglobinemia, a blood disorder. Extra caution is necessary for patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, those with heart or lung damage, infants under 6 months, and when used in conjunction with oxidizing agents. Symptoms may include bluish skin or abnormal changes in blood color, and if these occur, use should be immediately discontinued and medical attention sought. This drug should not be used for patients with hypersensitivity or wounds, mucous membranes, atopic dermatitis, infants under 3 months, and premature infants. Patients with anemia, liver disease, elderly patients, and those who are frail should use with caution, as skin reactions may occur. Common local reactions may include temporary symptoms such as pallor, redness, swelling, mild initial burning sensation, itching, tingling, skin irritation, and corneal irritation, while severe allergic reactions or anaphylactic shock may rarely occur. This drug can cause irritation if it comes into contact with the eyes, therefore it should not be used near the eyes or ears; if contact occurs, it should be washed immediately with clean water. Overdosage may lead to severe central nervous system and cardiovascular disturbances, so if symptoms arise, immediate medical treatment should be sought. The effects on the fetus during pregnancy have not been reported, but this drug should only be used when the benefits outweigh the risks, under a doctor's judgment. Nursing mothers should also be cautious as this drug may be excreted in breast milk. It should only be used sparingly in children, especially infants under 3 months, and should not be applied to the genital mucosa. The risk of methemoglobinemia may increase when used in conjunction with other medications, so if other medications are taken, it is essential to consult with a doctor or pharmacist. There have been reports of carcinogenic potential with high doses or long-term use of this drug, so it is important to adhere to the recommended dosage and duration of use.

Side effects

  • Pallor
  • erythema
  • edema
  • mild initial burning sensation
  • pruritus
  • purpura
  • petechiae
  • methemoglobinemia
  • allergic reactions
  • anaphylactic shock
Show 3 more
  • corneal irritation
  • paraesthesia
  • skin irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This will help maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

White cream

Package unit

For domestic use - 10 grams/tube, For domestic use - 100 grams/tube, For domestic use - 500 grams/bottle, For export - 10 grams/tube, For export - 100 grams/tube, For export - 500 grams/bottle, For export - 30 grams/tube

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.